Log In
Print this Print this

NCX 470

  Manage Alerts
Collapse Summary General Information
Company Nicox S.A.
DescriptionNitric oxide (NO)-donating bimatoprost
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma and ocular hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today